| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Suitable for: | Elderly, Children, Adult |
|
Still deciding? Get samples of US$ 10/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
INDICATIONS
1. This product is primarily used for all types of bleeding due to acute or chronic, limited or systemic primary fibrinolysis. It is generally not used in secondary hyperfibrinolytic states caused by disseminated intravascular coagulation prior to heparinization.
2. For trauma or surgical bleeding in fibrinogen-rich organs such as prostate, urethra, lung, brain, uterus, adrenal gland and thyroid.
3. Used as an antagonist of tissue-type fibrinogen activator (t-PA), streptokinase and urokinase.
4. For fibrinolytic bleeding due to miscarriage, early placental abruption, stillbirth and amniotic fluid embolism, and increased menorrhagia due to localized fibrinolytic lesions in the uterine cavity.
Adverse reactions
1. Occasionally, there is intracranial thrombosis and bleeding due to drug overdose.
2.There may be diarrhea, nausea, and vomiting.
3.Less commonly, there is menstrual discomfort (due to blood clotting during menstruation).4 Because the product can enter the cerebrospinal fluid, central nervous system symptoms such as blurred vision, headache, dizziness, and fatigue may occur after injection, especially in relation to the rate of injection, but are rare.
STORAGE
Store in a cool, dry & dark place.
Keep all medicines out of childen.
| Support OEM/ODM |
Yes |
| Standard Available |
CP,BP |
| Documents |
GMP,COPP,FSC,CTD |
){kind=link}